Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$167.3 million.

  • Medifast's Enterprise Value fell 303.61% to -$167.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$167.3 million, marking a year-over-year decrease of 303.61%. This contributed to the annual value of -$167.3 million for FY2025, which is 303.61% down from last year.
  • Medifast's Enterprise Value amounted to -$167.3 million in Q4 2025, which was down 303.61% from -$173.5 million recorded in Q3 2025.
  • Medifast's 5-year Enterprise Value high stood at -$61.1 million for Q2 2022, and its period low was -$212.9 million during Q1 2021.
  • Its 5-year average for Enterprise Value is -$146.0 million, with a median of -$158.8 million in 2021.
  • Per our database at Business Quant, Medifast's Enterprise Value skyrocketed by 6906.76% in 2022 and then crashed by 14137.45% in 2023.
  • Medifast's Enterprise Value (Quarter) stood at -$109.5 million in 2021, then grew by 19.95% to -$87.7 million in 2022, then tumbled by 71.1% to -$150.0 million in 2023, then fell by 8.2% to -$162.3 million in 2024, then decreased by 3.04% to -$167.3 million in 2025.
  • Its last three reported values are -$167.3 million in Q4 2025, -$173.5 million for Q3 2025, and -$162.7 million during Q2 2025.